By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
Helix (San Francisco) believes it can vastly expand the nascent consumer genomics market. The company, which announced backing from sequencing giant Illumina (San Diego), will launch a pay-as-you go genomic analysis service next year that has been dubbed an "enormous app store for genetic information." Helix backers say the company intends to bring consumer genomics into the…
Read more...
 Quadax delivers transformative revenue cycle management services through secure cloud-based systems to molecular diagnostic and genetic testing organizations across the United States. Our deep industry expertise enables us to implement successful strategies for overcoming the reimbursement challenges unique to this critical segment of our healthcare system. Quadax delivers customized solutions incorporating SaaS, outsourcing and hybrid offerings to meet the needs of providers in all laboratory disciplines. We build long-term partnerships with our clients, helping them optimize their financial performance and strengthen their market presence via our customer centric approach to support. For more information visit www.quadax.com
By Kelly A. Briganti, Editorial Director, G2 Intelligence
In a pilot project, more than 2,100 providers are increasing their skin in the game of value-based health care reimbursement by taking on financial risk. The Centers for Medicare & Medicaid Services (CMS) Innovation Center announced the Bundled Payments for Care Improvement Initiative in 2011 and began accepting applications for its first phase in 2012. The initiative tests how well bundling payment for episodes of…
Read more...
By Stephanie Murg, Managing Director, G2 Intelligence
With some 60% of its therapeutic candidates now being co-developed with companion diagnostics, Roche (Basel, Switzerland) is investing in both its diagnostics business and its drug pipeline with two recently announced acquisitions. The company has agreed to purchase microbiology diagnostics firm GeneWEAVE BioSciences (Los Gatos, Calif.) for $190 million plus up to…
Read more...
 CareEvolve's outreach connectivity solutions exchange laboratory results and orders between the Laboratory Information System and provider's Electronic Medical Record (EMR/EHR) systems. In addition to industry leading interconnectivity, CareEvolve includes a cloud-based Patient Results Portal, Provider Portal and data analytic functionality. The CareEvolve solutions are currently interfaced with over 300 EMR products and transfer orders and results for more than 30,000 providers. For more information, visit www.careevolve.com or call 888-322-5222.
By Ron Shinkman, Editor, Laboratory Industry Report
Miami-based OPKO Health has completed its acquisition of New Jersey-based Bio-Reference Laboratories.
Under the terms of the all-stock deal, Bio-Reference shareholders received 2.75 shares of OPKO stock in a deal worth just under $1.5 billion.
The deal was a small fish eating big fish transaction of sorts, with OPKO's annual revenues well under $100 million, while…
Read more...
|
